Sr. Public Health Advisor At The FDA Norman Birenbaum Says 45% Of The Hemp Drive Market Is Going To Be Topicals, Inhalables And Animal Products
Portfolio Pulse from Benzinga Newsdesk
Norman Birenbaum, a Senior Public Health Advisor at the FDA, has stated that 45% of the hemp drive market will be topicals, inhalables, and animal products. The news was reported by Benzinga, a financial news outlet.
September 28, 2023 | 2:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The AdvisorShares Pure US Cannabis ETF (MSOS) could be impacted by the FDA's prediction, as it invests in the US cannabis industry, which includes hemp products.
The FDA's prediction about the hemp market could potentially affect the performance of the MSOS ETF. As this ETF invests in the US cannabis industry, which includes hemp, a shift in market trends towards topicals, inhalables, and animal products could influence the returns of the companies in the ETF's portfolio.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75